Navigation Links
Elsevier announces new journal partnership for 2008
Date:12/6/2007

Oxford, UK, 6 December 2007 Elsevier is pleased to announce that in 2008 the leading fatty-acid research journal Prostaglandins, Leukotrienes & Essential Fatty Acids (PLEFA) will become the Official Journal of the International Society for the Study of Fatty Acids and Lipids (ISSFAL).

2008 also marks the journals 30th Anniversary. PLEFA was founded in 1978 as Prostaglandins and Medicine by the late David F Horrobin, and published by Churchill Livingstone. PLEFA addresses all aspects of the roles of lipids and their metabolites in cellular, organ and whole-organism function, and places a particular emphasis on human studies. The relevance of this research, including into omega-3 fatty acids, to the development of novel treatments for disease is growing.

Current Editor-in-Chief Mehar S Manku comments, The affiliation of ISSFAL to PLEFA is an important step in both the journal and societys growth and maturity. We warmly welcome ISSFAL members to PLEFA. Many ISSFAL members have previous experience of publication in PLEFA and therefore the association between the parties seems a natural one. We will work together to better understand the role of fatty acids and their several important bioactive metabolites in health and disease. Our common aim is to make PLEFA the leading journal in this field.

In addition, There is no doubt that in science, communication is crucial. ISSFAL has become the recognised scientific society in the field of lipids in nutrition, and as such needs a recognised medium to facilitate that communication. PLEFA is a key journal in this field, and so a link is logical between the two. ISSFAL is therefore pleased to make PLEFA the Official Journal of the Society. I wish every success for this promising joint venture, states Michel Lagarde, President of ISSFAL.

In 2008, all members of ISSFAL will have full online access to PLEFA, including its 30-year archive, online via a new site: www.PLEFA.com


'/>"/>

Contact: Andrew Miller
andrew.miller@elsevier.com
44-186-584-3823
Elsevier
Source:Eurekalert

Page: 1

Related biology news :

1. Institution of Chemical Engineers chooses Elsevier as publishing partner
2. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
3. LaserCard Corporation Announces Expansion of Middle East Project
4. BIO-key(R) Announces Contracts for New Criminal Justice Data Sharing Solution
5. Balzan Foundation announces 2007 winners
6. The American Society of Plant Biologists announces 2007 awards
7. ASPB announces Summer Undergraduate Research Fellowship 2007 recipients
8. NIST announces 56 new awards for innovative technology research and development
9. Titanium Group Announces Contract With Haitong Securities
10. Measurement Specialties, Inc. Announces Impact of German Business Tax Reform 2008 Resulting in Lower Combined German Tax Rate - Impacts 2Q08 Reported Financial Results
11. FIJI Water announces sustainable growth initiative with commitment to help mitigate climate change
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. , March ... Made Simple," and 23andMe , the leading personal ... food choices.  Zipongo can now provide customers with personalized ... health goals and biometrics, but also genetic markers impacting ... Zipongo,s personalized food decision support platform uses ...
(Date:3/2/2017)... 2017 Summary This report provides all ... partnering interests and activities since 2010. ... Read the full report: ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ...
(Date:3/1/2017)... March 1, 2017  Aware, Inc. (NASDAQ: AWRE), a ... Richard P. Moberg has resigned, effective March ... Chief Financial Officer and Treasurer of Aware citing a ... as a member of the Board of Directors of ... co-Chief Executive Officer and co-President, General Counsel has been ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... -- In today,s pre-market research, Stock-Callers.com takes ... industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals Inc. ... Regulus Therapeutics Inc. (NASDAQ: RGLS ). On ... rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more about ... ...
(Date:3/22/2017)... 2017  UBM and the Massachusetts Medical Device ... partnership and the third annual Massachusetts Medtech Week. Massachusetts ... st Annual MassMEDIC Conference held in conjunction ... 2017. MassMEDIC will feature a ... and CEO, Scott Whitaker , at its ...
(Date:3/22/2017)... Florida , March 22, 2017 ... ... various cancer conditions are being pressured as of late due ... for cancer pain management has a dramatic impact on patient,s ... research and development activities for identifying new forms of opioid ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced Tallahassee, ... their live events series, “Stem Cell Therapy: The Next Phase in the Evolution of ... Stem Cell Research and Therapy Act, Okyanos maintains a mission to help ...
Breaking Biology Technology: